187 related articles for article (PubMed ID: 9083293)
1. Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells.
van Setten PA; van Hinsbergh VW; van der Velden TJ; van de Kar NC; Vermeer M; Mahan JD; Assmann KJ; van den Heuvel LP; Monnens LA
Kidney Int; 1997 Apr; 51(4):1245-56. PubMed ID: 9083293
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.
van de Kar NC; Monnens LA; Karmali MA; van Hinsbergh VW
Blood; 1992 Dec; 80(11):2755-64. PubMed ID: 1333300
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome.
Van de Kar NC; Monnens LA; Van Hinsbergh VW
Behring Inst Mitt; 1993 Aug; (92):202-9. PubMed ID: 8250811
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C.
van de Kar NC; Kooistra T; Vermeer M; Lesslauer W; Monnens LA; van Hinsbergh VW
Blood; 1995 Feb; 85(3):734-43. PubMed ID: 7530504
[TBL] [Abstract][Full Text] [Related]
5. Verocytotoxin-induced apoptosis of human microvascular endothelial cells.
Pijpers AHJM; Setten PAV; Heuvel LPWJVD; Assmann KJM; Dijkman HBPM; Pennings AHM; Monnens LAH; Hinsbergh VWMV
J Am Soc Nephrol; 2001 Apr; 12(4):767-778. PubMed ID: 11274238
[TBL] [Abstract][Full Text] [Related]
6. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms.
Van Setten PA; van Hinsbergh VW; Van den Heuvel LP; van der Velden TJ; van de Kar NC; Krebbers RJ; Karmali MA; Monnens LA
J Am Soc Nephrol; 1997 Dec; 8(12):1877-88. PubMed ID: 9402090
[TBL] [Abstract][Full Text] [Related]
7. Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release.
van Setten PA; Monnens LA; Verstraten RG; van den Heuvel LP; van Hinsbergh VW
Blood; 1996 Jul; 88(1):174-83. PubMed ID: 8704172
[TBL] [Abstract][Full Text] [Related]
8. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
Louise CB; Obrig TG
Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
[TBL] [Abstract][Full Text] [Related]
9. Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions.
Morigi M; Micheletti G; Figliuzzi M; Imberti B; Karmali MA; Remuzzi A; Remuzzi G; Zoja C
Blood; 1995 Dec; 86(12):4553-8. PubMed ID: 8541545
[TBL] [Abstract][Full Text] [Related]
10. Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome.
te Loo DM; Monnens LA; van Der Velden TJ; Vermeer MA; Preyers F; Demacker PN; van Den Heuvel LP; van Hinsbergh VW
Blood; 2000 Jun; 95(11):3396-402. PubMed ID: 10828021
[TBL] [Abstract][Full Text] [Related]
11. Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress.
Morigi M; Galbusera M; Binda E; Imberti B; Gastoldi S; Remuzzi A; Zoja C; Remuzzi G
Blood; 2001 Sep; 98(6):1828-35. PubMed ID: 11535517
[TBL] [Abstract][Full Text] [Related]
12. The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies.
van de Kar NC; van Hinsbergh VW; Brommer EJ; Monnens LA
Pediatr Res; 1994 Aug; 36(2):257-64. PubMed ID: 7970942
[TBL] [Abstract][Full Text] [Related]
13. Endothelial heterogeneity in Shiga toxin receptors and responses.
Obrig TG; Louise CB; Lingwood CA; Boyd B; Barley-Maloney L; Daniel TO
J Biol Chem; 1993 Jul; 268(21):15484-8. PubMed ID: 8340376
[TBL] [Abstract][Full Text] [Related]
14. Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome.
Nestoridi E; Tsukurov O; Kushak RI; Ingelfinger JR; Grabowski EF
J Thromb Haemost; 2005 Apr; 3(4):752-62. PubMed ID: 15842359
[TBL] [Abstract][Full Text] [Related]
15. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.
Kaye SA; Louise CB; Boyd B; Lingwood CA; Obrig TG
Infect Immun; 1993 Sep; 61(9):3886-91. PubMed ID: 8359910
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.
Tesh VL; Samuel JE; Perera LP; Sharefkin JB; O'Brien AD
J Infect Dis; 1991 Aug; 164(2):344-52. PubMed ID: 1649877
[TBL] [Abstract][Full Text] [Related]
17. Expression of adhesion molecules by cultured human glomerular endothelial cells in response to cytokines: comparison to human umbilical vein and dermal microvascular endothelial cells.
Murakami S; Morioka T; Nakagawa Y; Suzuki Y; Arakawa M; Oite T
Microvasc Res; 2001 Nov; 62(3):383-91. PubMed ID: 11678640
[TBL] [Abstract][Full Text] [Related]
18. Shiga toxin 1 elicits diverse biologic responses in mesangial cells.
Simon M; Cleary TG; Hernandez JD; Abboud HE
Kidney Int; 1998 Oct; 54(4):1117-27. PubMed ID: 9767527
[TBL] [Abstract][Full Text] [Related]
19. Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells.
Te Loo DM; Monnens L; van der Velden T; Karmali M; van den Heuvel L; van Hinsbergh V
Pediatr Nephrol; 2006 Dec; 21(12):1815-23. PubMed ID: 16944213
[TBL] [Abstract][Full Text] [Related]
20. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
